Bellevue Group Ag Amneal Pharmaceuticals, Inc. Transaction History
Bellevue Group Ag
- $6.38 Billion
- Q1 2024
A detailed history of Bellevue Group Ag transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 45,387 shares of AMRX stock, worth $306,362. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,387
Previous 25,470
78.2%
Holding current value
$306,362
Previous $154,000
78.57%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AMRX
# of Institutions
178Shares Held
107MCall Options Held
330KPut Options Held
81.9K-
Vanguard Group Inc Valley Forge, PA13.7MShares$92.7 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$83.2 Million1.57% of portfolio
-
Fosun International LTD12.3MShares$83.1 Million54.23% of portfolio
-
Rubric Capital Management LP New York, NY9.54MShares$64.4 Million1.97% of portfolio
-
Black Rock Inc. New York, NY9.16MShares$61.9 Million0.0% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.02B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...